pubmed-article:18650640 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0040811 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0025202 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0018246 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C1843008 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0012737 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0684321 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0008902 | lld:lifeskim |
pubmed-article:18650640 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
pubmed-article:18650640 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:18650640 | pubmed:dateCreated | 2008-7-24 | lld:pubmed |
pubmed-article:18650640 | pubmed:abstractText | This study aims to objectively define the criteria for assessing the presence of lymphedema and to report the prevalence of lymphedema after inguinal and ilio-inguinal (inguinal and pelvic) lymph node dissection for metastatic melanoma. | lld:pubmed |
pubmed-article:18650640 | pubmed:language | eng | lld:pubmed |
pubmed-article:18650640 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18650640 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:18650640 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18650640 | pubmed:month | Aug | lld:pubmed |
pubmed-article:18650640 | pubmed:issn | 1528-1140 | lld:pubmed |
pubmed-article:18650640 | pubmed:author | pubmed-author:ThompsonJohn... | lld:pubmed |
pubmed-article:18650640 | pubmed:author | pubmed-author:TuckerMonicaM | lld:pubmed |
pubmed-article:18650640 | pubmed:author | pubmed-author:BythKarenK | lld:pubmed |
pubmed-article:18650640 | pubmed:author | pubmed-author:SawRobyn P... | lld:pubmed |
pubmed-article:18650640 | pubmed:author | pubmed-author:SpillaneAndre... | lld:pubmed |
pubmed-article:18650640 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18650640 | pubmed:volume | 248 | lld:pubmed |
pubmed-article:18650640 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18650640 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18650640 | pubmed:pagination | 286-93 | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:meshHeading | pubmed-meshheading:18650640... | lld:pubmed |
pubmed-article:18650640 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18650640 | pubmed:articleTitle | Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. | lld:pubmed |
pubmed-article:18650640 | pubmed:affiliation | Sydney Melanoma Unit at the Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, Australia. andrew.spillane@smu.org.au | lld:pubmed |
pubmed-article:18650640 | pubmed:publicationType | Journal Article | lld:pubmed |